Clinical research platform uMotif has raised £20 million from a New York investment firm. The London company’s patient-first software platform is available on any device and designed to service pharmaceutical, BioTech, MedTech and contract research organisation clients including AstraZeneca. Deployed in more than 30 countries globally, it claims to deliver high rates of data capture, … Continue reading Clinical research platform uMotif raises £20m US investment